Loading data for CVS — first visit, this takes a few seconds.

알림

CVS Health Corporation (CVS)

NYSE: CVS · 실시간 가격 · USD

94.01

-3.15 (-3.24%)

종가 기준: Aug 19, 2026, 10:52 AM

-3.24% (1D)

매수호가	n/a
시가총액	121.71B
매출 (ttm)	412.64B
순이익 (ttm)	4.89B
베타	0.60
EPS (ttm)	3.79
P/E (ttm)	25.11
선행 P/E	11.19
P/B (ttm)	1.53
P/S (ttm)	0.29
Earnings Date	Oct 28, 2026

매도호가	94.23
거래량	7,295,683
평균 거래량 (20일)	8,175,018
시가	96.29
전일 종가	97.16
일중 범위	93.74 - 96.30
52주 범위	69.51 - 110.68
애널리스트	n/a
목표주가	n/a
배당	$2.66 (2.8%)
배당락일	2026년 7월 23일

CVS 소개

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer...

[더 보기]

산업 Healthcare Plans

섹터 Healthcare

IPO 일자 Feb 21, 1973

직원 수 219,000

상장 거래소 NYSE

티커 CVS

웹사이트 https://www.cvshealth.com

전체 기업 정보

재무 실적

2025년 CVS Health의 매출은 402.07B로, 전년 372.81B 대비 7.85% 증가했습니다. 순이익은 1.77B로, -61.68% 감소했습니다.

재무제표

어닝 서프라이즈

CVS Health가 Aug 5, 2026에 분기 실적을 발표했습니다:

매출 $106.1B 예상치 하회 $0, 및 7.26% 전년 대비 성장.

EPS 2.58 예상치 상회 0.73, 및 42.54% 전년 대비 성장.

다음 실적 발표

CVS Health Corporation의 실적 발표 예정일은 Oct 28, 2026, 장 시작 전입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

1일 전 · Zacks

Is CVS Stock a Buy as Earnings Improve but Key Risks Remain Elevated?

CVS Health enters the second half of 2026 with stronger earnings and Aetna gains, but medical costs and Caremark risks cloud the recovery.

1일 전 · Zacks

CVS' Q2 EPS Gains From Improved Health Care Benefits Profitability

CVS Health's Q2 EPS jumps more than 40% as Health Care Benefits profitability improves, prompting a major boost to its 2026 AOI outlook.

4일 전 · Zacks

Can CVS Sustain Its 2026 Recovery After Raising Earnings Guidance?

CVS Health is rebuilding momentum as Aetna drives stronger profits and higher 2026 guidance, but medical costs and PBM changes could test the recovery.

4일 전 · Zacks

How CVS Is Building on Its Consumer-Health Care Technology Push

CVS Health advances its $20 billion technology push with AI tools, Health100 and automation aimed at simplifying care and improving engagement.

5일 전 · Simply Wall St.

CVS Health (CVS) Rolls Out New PBM Tools As Employer Trust Grows

CVS Health (NYSE:CVS) reports that employers show higher trust in pharmacy benefit managers to manage drug costs and access to complex treatments, according to a new CVS Caremark survey. The company i...

2 페이지 중 1

CVS Health Corporation (CVS)